Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries.

Autor: Jakubowski S; Department of Health Promotion and e-Health, Faculty of Health of Science, Jagiellonian University Medical College, Kraków, Poland., Kawalec P; Department of Nutrition and Drug Research, Faculty of Health of Science, Jagiellonian University Medical College, Kraków, Poland., Holko P; Department of Nutrition and Drug Research, Faculty of Health of Science, Jagiellonian University Medical College, Kraków, Poland., Kowalska-Bobko I; Health Policy and Management Department, Faculty of Health of Science, Jagiellonian University Medical College, Kraków, Poland., Kamusheva M; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Petrova G; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Draganić P; Agency for Medicinal Products and Medical Devices of Croatia, Zagreb, Croatia.; Department of Biotechnology, University of Rijeka, Rijeka, Croatia., Fuksa L; Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Prague, Czechia., Männik A; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia., Ispán F; Department of Reimbursement, National Institute of Health Insurance Fund Management, Budapest, Hungary., Briedis V; Department of Clinical Pharmacy of Lithuanian, University of Health Sciences, Kaunas, Lithuania., Bianchi I; The Romanian Association of International Medicine Manufacturers. ARPIM, Bucharest, Romania., Paveliu MS; Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania., Tesar T; Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2024 Mar 08; Vol. 15, pp. 1369178. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries.

Autor: Jakab I; Syreon Research Institute, Budapest, Hungary.; Patient advocate, Budapest, Hungary., Dimitrova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Houÿez F; European Organisation for Rare Diseases (EURORDIS), Paris, France., Bereczky T; Patvocates GmbH, Riemerling, Germany., Fövényes M; Lymfoma Slovensko, Bratislava, Slovakia., Maravic Z; Digestive Cancers Europe, Brussels, Belgium., Belina I; Coalition of Associations in Healthcare, Zagreb, Croatia., Andriciuc C; Romanian Federation of Diabetes Associations, Cluj Napoca, Romania., Tóth K; Syreon Research Institute, Budapest, Hungary.; Bridge of Health Alliance against Breast Cancer Association, Budapest, Hungary., Piniazhko O; Health Technology Assessment Department of State Expert Centre, Ministry of Health of Ukraine, Kyiv, Ukraine., Hren R; Syreon Research Institute, Budapest, Hungary.; Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia., Gutierrez-Ibarluzea I; Basque Foundation for Health Innovation and Research, Landa, Spain., Czech M; Head of Pharmacoeconomic Department, Institute of Mother and Child, Warsaw, Poland., Tesar T; Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia., Niewada M; Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland., Lorenzovici L; Syreon Research Romania, Tirgu Mures, Romania.; Department of Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology, Targu Mures, Romania., Kamusheva M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Manova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Savova A; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Mitkova Z; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Tachkov K; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Németh B; Syreon Research Institute, Budapest, Hungary., Petykó ZI; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary., Dawoud D; Science, Policy and Research Programme, National Institute for Health and Care Excellence, London, United Kingdom., Delnoij D; National Health Care Institute (ZIN), Diemen, Netherlands., Knies S; National Health Care Institute (ZIN), Diemen, Netherlands., Goettsch W; National Health Care Institute (ZIN), Diemen, Netherlands.; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands., Kaló Z; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary.

Publikováno v: Frontiers in public health [Front Public Health] 2023 Jul 03; Vol. 11, pp. 1176200. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).

Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.

Autor: Zemplényi A; Center for Health Technology Assessment and Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.; Syreon Research Institute, Budapest, Hungary., Tachkov K; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Balkanyi L; Medical Informatics R&D Center, Pannon University, Veszprém, Hungary., Németh B; Syreon Research Institute, Budapest, Hungary., Petykó ZI; Syreon Research Institute, Budapest, Hungary., Petrova G; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Czech M; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Dawoud D; Science Policy and Research Programme, Science Evidence and Analytics Directorate, National Institute for Health and Care Excellence (NICE), London, United Kingdom.; Cairo University, Faculty of Pharmacy, Cairo, Egypt., Goettsch W; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands.; National Health Care Institute, Diemen, Netherlands., Gutierrez Ibarluzea I; Basque Foundation for Health Innovation and Research, Barakaldo, Spain., Hren R; Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia., Knies S; National Health Care Institute, Diemen, Netherlands., Lorenzovici L; Syreon Research Romania, Tirgu Mures, Romania.; G. E. Palade University of Medicine, Pharmacy, Science and Technology, Tirgu Mures, Romania., Maravic Z; Digestive Cancers Europe, Brussels, Belgium., Piniazhko O; HTA Department of State Expert Centre of the Ministry of Health of Ukraine, Kyiv, Ukraine., Savova A; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council of Prices and Reimbursement of Medicinal Products, Sofia, Bulgaria., Manova M; Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council of Prices and Reimbursement of Medicinal Products, Sofia, Bulgaria., Tesar T; Department of Organisation and Management of Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia., Zerovnik S; Ministry of Health, Ljubljana, Slovenia., Kaló Z; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary.

Publikováno v: Frontiers in public health [Front Public Health] 2023 Apr 26; Vol. 11, pp. 1088121. Date of Electronic Publication: 2023 Apr 26 (Print Publication: 2023).